The Open Public Hearing at FDA Advisory Committee Meetings: Guidance for the Public, FDA Advisory Committee Members, and FDA Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 15, 2013
April 21, 2019
c9efbd34-43c9-45a4-ab0c-38fd2d0d07bd
Related Documents
Guidance for Hospitals, Nursing Homes, and Other Health Care Facilities - FDA Public Health Advisory: Guidance for Hospitals, Nursing Homes, and Other Health Care Facilities
Guidance DocumentApril 5, 2001Center for Drug Evaluation and Research
Compliance Policy for Combination Product Postmarketing Safety Reporting: Immediately in Effect Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentApril 20, 2019Office of the Commissioner
Public Availability of Advisory Committee Members' Financial Interest Information and Waivers: Guidance for the Public, FDA Advisory Committee Members, and FDA Staff
Guidance DocumentFebruary 28, 2014Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.